Viser 401 - 416 av 416 resultater
Tid Selskap Tittel Sektor Kategori
11 Jul 2023
18:00 CEST
IPSEN IPSEN - Buy-back programme - Art 5 of MAR - Week 27 - 2023 20103015 Pharmaceuticals Share history
11 Jul 2023
18:00 CEST
IPSEN IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 27 - 2023 20103015 Pharmaceuticals Share history
10 Jul 2023
18:00 CEST
IPSEN Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital 20103015 Pharmaceuticals Share history
10 Jul 2023
18:00 CEST
IPSEN Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social 20103015 Pharmaceuticals Share history
10 Jul 2023
18:00 CEST
IPSEN Ipsen – Half year statement – 2023 06 30 20103015 Pharmaceuticals Share history
10 Jul 2023
18:00 CEST
IPSEN Ipsen – Bilan semestriel – 2023 06 30 20103015 Pharmaceuticals Share history
04 Jul 2023
18:00 CEST
IPSEN IPSEN - Buy-back programme - Art 5 of MAR - Week 26 - 2023 20103015 Pharmaceuticals Share history
04 Jul 2023
18:00 CEST
IPSEN IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 26 - 2023 20103015 Pharmaceuticals Share history
30 Jun 2023
07:00 CEST
IPSEN Ipsen and GENFIT Announce Positive Results from Phase III ELATIVE trial of elafibranor in patients with primary biliary cholangitis, a rare cholestatic liver disease 20103015 Pharmaceuticals Products and services
30 Jun 2023
07:00 CEST
IPSEN Ipsen et GENFIT annoncent les résultats positifs de l'essai de Phase III ELATIVE évaluant elafibranor chez des patients atteints de cholangite biliaire primitive, une maladie cholestatique rare du foie 20103015 Pharmaceuticals Products and services
29 Jun 2023
02:00 CEST
IPSEN Ipsen announces positive outcome of FDA Advisory Committee on investigational palovarotene for fibrodysplasia ossificans progressiva 20103015 Pharmaceuticals Products and services
29 Jun 2023
02:00 CEST
IPSEN Ipsen annonce les résultats positifs du comité consultatif de la FDA sur le palovarotène expérimental pour la fibrodysplasie ossifiante progressive 20103015 Pharmaceuticals Products and services
27 Jun 2023
18:00 CEST
IPSEN IPSEN - Buy-back programme - Art 5 of MAR - Week 25 - 2023 20103015 Pharmaceuticals Share history
27 Jun 2023
18:00 CEST
IPSEN IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 25 - 2023 20103015 Pharmaceuticals Share history
20 Jun 2023
18:00 CEST
IPSEN IPSEN - Buy-back programme - Art 5 of MAR - Week 24 - 2023 20103015 Pharmaceuticals Share history
20 Jun 2023
18:00 CEST
IPSEN IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 24 - 2023 20103015 Pharmaceuticals Share history